Sophia Shakur, MD
Neurological Surgery · Salisbury, MDNPI 1336308071
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,041 of the $14,499 with a category attached, or 69.3%. 44 manufacturers reported payments, led by Stryker at 30.9% of the total. Reporting peaked in 2021 at $3,705 and has fallen 59.1% since, to $1,516 in 2025.
Across 256 payments — averaging $56.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Johnson & Johnson$2K
- Medical Device Business Services, Inc.$2K
- Medtronic$2K
- Abbott$1K
- Globus Medical$772
- plus $3K from 38 others
What the payments were for
- Speaking & faculty fees$220%
- Travel & lodging$4,43431%
- Food & beverage$10,04169%
- Gifts$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 71 | $4,481 |
| Johnson & Johnson | 33 | $1,800 |
| Medical Device Business Services, Inc. | 8 | $1,674 |
| Medtronic(3 entities) | 36 | $1,546 |
| Abbott | 17 | $1,035 |
| Globus Medical | 3 | $772 |
| Rapid Medical Ltd | 3 | $431 |
| Boston Scientific | 3 | $268 |
| Route 92 Medical, Inc. | 3 | $217 |
| AbbVie | 11 | $207 |
| Varian Medical Systems, Inc. | 2 | $199 |
| Nevro Corp. | 3 | $166 |
| Zimmer Biomet | 2 | $145 |
| AstraZeneca(2 entities) | 7 | $125 |
| Penumbra, Inc. | 5 | $124 |
| 7d Surgical Inc. | 1 | $118 |
| Amgen | 5 | $115 |
| 4web, Inc. | 1 | $114 |
| Baxter Healthcare | 2 | $91 |
| Kls-martin L.p. | 3 | $63 |
| Lilly USA, LLC | 3 | $60 |
| Biogen | 3 | $57 |
| Si-bone, Inc. | 3 | $55 |
| Integra Lifesciences Corporation | 2 | $52 |
| Lundbeck LLC | 2 | $49 |
| Genentech USA, Inc. | 2 | $48 |
| Neurocrine Biosciences, Inc. | 2 | $46 |
| Supreme Orthopedic Systems, LLC | 1 | $41 |
| Livanova USA, Inc. | 3 | $39 |
| EMD Serono, Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $32 |
| UCB, Inc. | 1 | $30 |
| Lifenet Health | 1 | $29 |
| Intrinsic Therapeutics | 1 | $29 |
| Imperative Care, Inc | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Tanabe Pharma America, Inc. | 1 | $22 |
| Acorda Therapeutics, Inc | 1 | $22 |
| Pfizer | 1 | $21 |
| Molnlycke Health Care US, LLC | 1 | $19 |
| Sanofi | 1 | $19 |
| Orthofix Medical, Inc. | 1 | $18 |
| DJO, LLC | 1 | $15 |
| Eisai Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVOLVE$1,635
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$1,505
- TRUFILL$1,505
- ExcelsiusGPS Robotic Navigation System$624
- Rist-5F$491
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$431
- COMANECI 17$431
- EMBOTRAP II Revascularization Device$231
- SURPASS$167
- SYNCHROMEDII$160
- WaveWriter Alpha Prime 16$138
- PROCLAIM$138
- CEREBASE$125
- Embotrap$125
- EMBOGUARD$125
- SPINE TRUSS SYSTEM$114
- Edge$111
- Omnia$110
- Axium INS DRG IPG$108
- SURPASS EVOLVE$107
How this compares
$14,499 in reported general payments places this provider in the 75th percentile of 133 neurological surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 26 | $738 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 58 | $536 |
| ClopidogrelClopidogrel Bisulfate | 15 | $160 |
| Oxycodone Hcl | 18 | $102 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Salisbury
- Alexander CoonBaltimore$2.7M
- Charles SansurBaltimore$1.8M
- Faheem SandhuClinton$1.5M
- Nicholas TheodoreBaltimore$833K
- Daniel SciubbaBaltimore$789K
- Hugo BenalcazarBel Air$380K
- Henry BremBaltimore$353K
- Ira GaronzikBaltimore$297K
- James ConwayBaltimore$273K
- Gary DixAnnapolis$230K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.